Long-term treatment for lifetime disorders?
Greden
J F
JF
Schizophrenia Program, University of Michigan Medical Center, Ann Arbor 48109-0704.
Tandon
R
R
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D015201:Meta-Analysis as Topic; D019964:Mood Disorders / Q000188:drug therapy / Q000517:prevention & control; D012008:Recurrence; D012307:Risk Factors; D012559:Schizophrenia / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000517:prevention & control
D014150:Antipsychotic Agents